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ongoing myocardial infarction. Patients who underwent cardiac
catheterization without an obvious culprit lesion corresponding to the
ECG changes were also included as false STEMI. The diagnoses were
obtained based upon the clinical presentation and ECG ﬁndings as
well as transthoracic echocardiogram and coronary angiography
ﬁndings in some cases.
RESULTS Of the 431 STEMI activations, (356/431) 82.6% were males
and 17.4% (75/431) were females. The overall false STEMI activation
rate was 35.3% (152/431). There were 23% (35/152) females and 77 %
(117/152) males who had false STEMI activations (p 0.023). The most
frequent cause for false STEMI activation was abnormal ECG ﬁndings-
19% (29/152), of which presumed new Left Bundle Branch Block
accounted for 48% of these. 12.5% had non cardiac chest pain (19/152)
and 11.8% (18/152) had Non STEMI (NSTEMI). Coronary artery vaso-
spasm occurred in 7.9% (12/152) of cases. Pericarditis was diagnosed in
(6.6%) 10/152 and severe hypertension in 5.9% (9/152). There were
5.2% cases (8/152) with a diagnosis of acute or decompensated
Congestive Heart Failure (CHF), unstable angina and syncope each.
4.6% (7/152) had cardiac arrest. Pericardial effusion was found in 3.3%
(5/152) patients. Three patients (2%) were diagnosed each with Bru-
gada and Takotsubo. Two patients (1.3%) had pulmonary embolism
(PE), aortic dissection and Implantable Cardioverter Deﬁbrillator (ICD)
shocks each. Less common causes were endocarditis, Intracranial
Hemorrhage (ICH), Subdural Hematoma, severe Aortic Regurgitation
(AR), severe anemia, ventricular aneurysm and sepsis where 1 case of
each was observed.
CONCLUSIONS The commonest reason for False STEMI activation
was the ﬁnding of an abnormal ECG. Presumed new LBBB accounted
for 48% of the ECG abnormalities.
CATEGORIES CORONARY: Acute Myocardial Infarction
KEYWORDS ST-segment elevation myocardial infarction
TCT-259
Impact of ECG-Deﬁned Infarct Location on Mortality in Patients with STEMI
Undergoing Primary PCI: Insights from the HORIZONS-AMI Trial
Gennaro Giustino,1 Joe Dizon,2 Philippe Genereux,3 Roxana Mehran,4
Mario Gössl,5 Bernard j Gersh,6 Girma M. Ayele,7 Gregg W. Stone8
1Icahn School of Medicine at Mount Sinai, New York City, NY;
2Columbia University, New York, NY; 3Columbia University Medical
Center, New York; 4Icahn School of Medicine at Mount Sinai, New York,
United States; 5Mayo Clinic, Rochester, MN; 6Mayo Clinic College of
Medicine, Rochester, United States; 7Cardiovascular Research
Foundation, New York, NY; 8Columbia University Medical Center and
the Cardiovascular Research Foundation, New York, NY
BACKGROUND Anterior ST-segment elevation infarction (A-STEMI) is
associated with larger infarct size and greater reduction in left ven-
tricular ejection fraction (LVEF) compared with non-anterior STEMI
(NA-STEMI). Whether or not ECG-deﬁned STEMI location predicts
long-term mortality after primary percutaneous coronary intervention
(PPCI) is unclear. We sought to investigate: (i) the clinical and quan-
titative coronary angiography (QCA) characteristics of patients with
ECG-deﬁned A- and NA-STEMI, and (ii) the unadjusted andindependent long-term prognostic impact of ECG-deﬁned STEMI
location in patients undergoing PPCI.
METHODS Participants from the HORIZONS-AMI trial were catego-
rized according to A-STEMI vs. NA-STEMI ECG-deﬁned STEMI loca-
tion. By ECG core laboratory analysis, A-STEMI was deﬁned as an ST-
elevation in the anterior (V2-4) or anteroseptal (V1-3) ECG leads. Pri-
mary endpoint of interest was all-cause mortality at 3 years. Adjusted
associations with 3-year mortality were estimated by Cox proportional
hazards modeling.
RESULTS Among 2,578 patients undergoing PPCI with core laboratory
determined STEMI location, 765 (29.7%) and 1813 (70.3%) hadA-STEMI and
NA-STEMI respectively. Patients with A-STEMI were older and had lower
baseline LVEF. Left anterior descending (LAD) artery was the culprit artery
in 90.9% of A-STEMIs, while the right coronary and left circumﬂex (LCX)
were the culprit arteries in 61.7% and 17.4%of NA-STEMIs, respectively. By
QCA, lesion length was longer, and thrombus, calciﬁcation, and type B2/C
lesions were more prevalent in NA-STEMI. At 3 years, patients with A-
STEMI had higher unadjusted rates of 3-year all-cause mortality (7.6% vs.
4.8%; p¼ 0.004). This association persisted aftermultivariable adjustment
for baseline clinical confounders (hazard ratio [HR]: 1.42; 95% conﬁdence
interval [CI]: 1.19 – 1.69; p<0.0001). However, after includingQCAvariables
in the multivariable model, ECG-deﬁned A-STEMI had no effect on 3-year
mortality (HR: 1.03; 95% CI: 0.77 – 1.37; p¼0.84); conversely, QCA variables
such as LAD as a culprit artery, presence of LCX plaques with > 50% di-
ameters stenosis (DS), presence of left main plaques with > 50% DS, and
total lesion length did.
CONCLUSIONS ECG-deﬁned A-STEMI was associated with greater
long-term mortality in patients undergoing primary PCI from HORI-
ZONS-AMI. QCA variables, however, including infarct artery location,
had better long-term prognostic value than ECG-deﬁned STEMI
location.
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BACKGROUND It is known that elevated inﬂammatory biomarkers
were associated with clinical outcomes of patients with ST-segment
elevated myocardial infarction (STEMI). This study investigated the
usefulness of a novel inﬂammation-based prognostic system, named
the combination of platelet count and neutrophil-lymphocyte ratio
(COP-NLR) for predicting prognosis of patients with STEMI.
METHODS We analysis 305 consecutive patients with STEMI treated
with primary PCI. The COP-NLR was calculated as follows: patients
with both an elevated platelet count (> 300  109/l) and neutrophil
lymphocyte ratio (> 3) were allocated a score of 2 and patients
showing one or neither were allocated a score of 1 or 0, respectively.
RESULTS The patients with COP-NLR score 0, 1, and 2 was 102, 149,
and 23 patients, respectively. The peak CK-MB (181.4 ng/ml, 219.7 ng/
ml, and 265.1 ng/ml, respectively, ANOVA P ¼ 0.070) and Troponin T
numerically increased according to COP-NLR score (0.63 ng/ml, 0.78
ng/ml, and 1.57 ng/ml, respectively, ANOVA P ¼ 0.059). During the
PCI, no-reﬂow tended to be observed more frequently in patients with
score 2 (2.8%, 4.7%, and 10.3%, respectively, P ¼ 0.117).The in-hospital
mortality was highest in COP-NLR score 2 (0%, 4.7%, and 13.8%,
respectively, P ¼ 0.002). The Kaplan-Meier curve showed that higher
COP-NLR score signiﬁcantly associated with major cardiovascular
adverse events in 12-month follow-up.
Short-term and long-term clinical outcomes according to COP-NLR scoreCOP-NLR score 0
N [ 106COP-NLR score 1
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N[25 P-valueIn-hospital death 0, 0% 8, 4.7% 4, 13.8% 0.001All cause death 0, 0% 9, 5.3% 4, 13.8% 0.003Non-fatal MI 3, 2.8% 3, 1.8% 1, 3.4% 0.771TLR 5, 4.7% 3, 1.8% 0, 5% 0.231MACE 7, 6.6% 16, 9.4% 6, 20.7% 0.072
